Page last updated: 2024-09-02

1-hydroxymethylmidazolam and Body Weight

1-hydroxymethylmidazolam has been researched along with Body Weight in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bartkowska-Sniatkowska, A; Bienert, A; Grześkowiak, E; Grześkowiak, M; Kaliszan, R; Rosada-Kurasińska, J; Sokołowska, A; Teżyk, A; Wiczling, P; Zaba, C1
Goh, BC; Hee, KH; Lee, LS; Sapari, NS; Seng, KY; Soon, GH; Soong, R1
Fleishaker, JC; Hopkins, NK; Pearson, LK; Pearson, PG; Peters, GR; Wienkers, LC1

Trials

3 trial(s) available for 1-hydroxymethylmidazolam and Body Weight

ArticleYear
Assessing circadian rhythms during prolonged midazolam infusion in the pediatric intensive care unit (PICU) children.
    Pharmacological reports : PR, 2013, Volume: 65, Issue:1

    Topics: Adolescent; Blood Pressure; Body Temperature; Body Weight; Cardiac Output; Child; Child, Preschool; Circadian Rhythm; Critical Illness; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Hypnotics and Sedatives; Infant; Infusions, Intravenous; Intensive Care Units, Pediatric; Male; Midazolam; Models, Biological; Nonlinear Dynamics; Respiration, Artificial; Time Factors

2013
CYP3A5*3 and bilirubin predict midazolam population pharmacokinetics in Asian cancer patients.
    Journal of clinical pharmacology, 2014, Volume: 54, Issue:2

    Topics: Adult; Aged; Anti-Anxiety Agents; Asian People; Bilirubin; Body Weight; Creatinine; Cytochrome P-450 CYP3A; Female; Genotype; Glucuronosyltransferase; Humans; Injections, Intravenous; Male; Midazolam; Middle Aged; Neoplasms; Polymorphism, Genetic

2014
Hormonal effects on tirilazad clearance in women: assessment of the role of CYP3A.
    Journal of clinical pharmacology, 1999, Volume: 39, Issue:3

    Topics: Adolescent; Adult; Age Factors; Aged; Antioxidants; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Body Weight; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Estrogens; Female; Hormone Replacement Therapy; Humans; Metabolic Clearance Rate; Midazolam; Middle Aged; Oxidoreductases, N-Demethylating; Postmenopause; Pregnatrienes; Premenopause; Progesterone

1999